These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND IGH AND Treatment
194 results:

  • 1. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR and ddPCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM
    Methods Mol Biol; 2025; 2865():189-219. PubMed ID: 39424725
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy.
    Vervoordeldonk MYL; Hengeveld PJ; Levin MD; Langerak AW
    Leuk Lymphoma; 2024 Aug; 65(8):1031-1043. PubMed ID: 38619476
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The first case of six-way complex translocation of t(4;7;9;22;8;14) in a patient with chronic myeloid leukemia.
    Bi X; Li C; Shang M; Han B; Li H; Sun L; Lin Y; Yang S
    J Hematop; 2024 Jun; 17(2):97-101. PubMed ID: 38492169
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Factors in Philadelphia Chromosome-Positive Acute Myeloid leukemia Using Fluorescence in Situ Hybridization.
    Zhang Z; Sun C; Cai L; Chen Y; Zhou X; Chen S; Feng X; Yang X; Li Q; Liu L; Zhou H; Li B
    Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345995
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms.
    Liu Y; Ho C; Yu W; Huang Y; Miller J; Gao Q; Syed M; Ma Y; Wang M; Maciag L; Petrova-Drus K; Zhu M; Yao J; Vanderbilt C; Durham B; Benhamida J; Ewalt MD; Dogan A; Roshal M; Nafa K; Arcila ME
    J Mol Diagn; 2024 Mar; 26(3):168-178. PubMed ID: 38103591
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
    Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
    Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].
    Cui CH; Chang YN; Zhou J; Li CW; Wang HJ; Sun Q; Jia YJ; Li QH; Wang TY; Qiu LG; Yi SH
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):418-423. PubMed ID: 37550193
    [No Abstract]    [Full Text] [Related]  

  • 8. 'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
    Gupta DG; Varma N; Sreedharanunni S; Abdulkadir SA; Naseem S; Sachdeva MUS; Binota J; Bose P; Malhotra P; Khadwal A; Varma S
    Br J Cancer; 2023 Jul; 129(1):143-152. PubMed ID: 37156894
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
    Avenarius MR; Huang Y; Hyak J; Byrd JC; Bhat SA; Grever M; Kittai AS; Rogers KA; Jones D; Zhao W; Heerema NA; Abruzzo LV; Woyach J; Miller CR
    Hematol Oncol; 2023 Oct; 41(4):771-775. PubMed ID: 37010242
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)].
    Yang H; Guo R; Shi Y; Qiao C; Wu YJ; Fan L; Xu W; Miao KR; Li JY; Qiu HR
    Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):674-679. PubMed ID: 36709153
    [No Abstract]    [Full Text] [Related]  

  • 11. 5' Rapid amplification of cDNA ends (5'RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia.
    Lan X; Ruminy P; Bohers E; Rainville V; Viennot M; Viailly PJ; Etancelin P; Tilly H; Mihailescu S; Bouclet F; Leprêtre S; Jardin F
    Leuk Res; 2022 Dec; 123():106952. PubMed ID: 36272389
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma.
    Barnell EK; Skidmore ZL; Newcomer KF; Chavez M; Campbell KM; Cotto KC; Spies NC; Ruzinova MB; Wang T; Abro B; Kreisel F; Parikh BA; Duncavage EJ; Frater JL; Lee YS; Hassan A; King JA; Kohnen DR; Fiala MA; Welch JS; Uy GL; Vij K; Vij R; Griffith M; Griffith OL; Wartman LD
    Blood Adv; 2023 Jan; 7(2):236-245. PubMed ID: 36251745
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia.
    Mai H; Li Q; Wang G; Wang Y; Liu S; Tang X; Chen F; Zhou G; Liu Y; Li T; Wang L; Wang C; Wen F; Liu S
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3259-3266. PubMed ID: 35918464
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. TRAF3 alterations are frequent in del-3'igh chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features.
    Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Santos-Mínguez S; Miguel-García C; Vidal MJ; García-De-Coca A; Galende J; Pardal E; Aguilar C; Vargas-Pabón M; Dávila J; Gascón-Y-Marín I; Hernández-Rivas JÁ; Benito R; Hernández-Rivas JM; Rodríguez-Vicente AE
    Am J Hematol; 2022 Jul; 97(7):903-914. PubMed ID: 35472012
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.
    Adamia S; Bhatt S; Wen K; Chyra Z; Fell GG; Tai YT; Pioso MS; Abiatari I; Letai A; Dorfman DM; Hideshima T; Anderson KC
    Leukemia; 2022 Apr; 36(4):1088-1101. PubMed ID: 35082402
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia.
    Schmid VK; Khadour A; Ahmed N; Brandl C; Nitschke L; Rajewsky K; Jumaa H; Hobeika E
    Haematologica; 2022 Aug; 107(8):1796-1814. PubMed ID: 35021605
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)/CCND1-igh: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma.
    Zhao Y; McCracken J; Rehder C; Wang E
    Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e310-e313. PubMed ID: 34840090
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targets.
    Carlet M; Völse K; Vergalli J; Becker M; Herold T; Arner A; Senft D; Jurinovic V; Liu WH; Gao Y; Dill V; Fehse B; Baldus CD; Bastian L; Lenk L; Schewe DM; Bagnoli JW; Vick B; Schmid JP; Wilhelm A; Marschalek R; Jost PJ; Miething C; Riecken K; Schmidt-Supprian M; Binder V; Jeremias I
    Nat Commun; 2021 Sep; 12(1):5655. PubMed ID: 34580292
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Molecular pathogenesis and treatment of chronic lymphocytic leukemia].
    Suzuki R
    Rinsho Ketsueki; 2021; 62(8):1085-1093. PubMed ID: 34497195
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia.
    Costa D; Granada I; Espinet B; Collado R; Ruiz-Xivillé N; Puiggros A; Uribe M; Arias A; Gómez C; Delgado J; Pereira A; Magnano L; Colomer D; López C; Beà S
    Genes Chromosomes Cancer; 2022 Jan; 61(1):37-43. PubMed ID: 34414624
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 10.